Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-23

FDA Approved: TOPIRAMATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Topiramate from Aurobindo Pharma Limited under an existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)